Growing community of inventors

Edmonton, Canada

Mark J Krantz

Average Co-Inventor Count = 4.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 30

Mark J Krantz ↔ B Michael Longenecker (3 patents)Mark J Krantz ↔ R Rao Koganty (2 patents)Mark J Krantz ↔ Wladyslaw A Budzynski (2 patents)Mark J Krantz ↔ Babita Agrawal (1 patent)Mark J Krantz ↔ Damayanthi Yalamati (3 patents)Mark J Krantz ↔ Zi-Hua Jiang (3 patents)Mark J Krantz ↔ Sham Gandhi (2 patents)Mark J Krantz ↔ Mark A Reddish (1 patent)Mark J Krantz ↔ Michael B Longenecker (0 patent)Mark J Krantz ↔ Rao Koganty (0 patent)Mark J KrantzMark J Krantz (3 patents)B Michael LongeneckerB Michael Longenecker (14 patents)R Rao KogantyR Rao Koganty (7 patents)Wladyslaw A BudzynskiWladyslaw A Budzynski (4 patents)Babita AgrawalBabita Agrawal (10 patents)Damayanthi YalamatiDamayanthi Yalamati (3 patents)Zi-Hua JiangZi-Hua Jiang (3 patents)Sham GandhiSham Gandhi (2 patents)Mark A ReddishMark A Reddish (1 patent)Michael B LongeneckerMichael B Longenecker (0 patent)Rao KogantyRao Koganty (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Oncothyreon Inc. (2 from 10 patents)

2. Biomira, Inc. (1 from 16 patents)


3 patents:

1. 8552145 - Vaccine for modulating between T1 and T2 immune responses

2. 8198400 - Vaccine for modulating between T1 and T2 immune responses

3. 6600012 - Lipid-modified muc-1 derivatives

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/14/2026
Loading…